Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC
Clinical trial NCT04313504 · COMPLETED
Trial details
- NCT number
- NCT04313504
- Sponsor
- Trisha Wise-Draper
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2025-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.